Your browser doesn't support javascript.
Long-Term Results of the Treatment of Patients With Chronic Ischemia of the Lower Limbs in Combination With Ischemic Heart Disease.
Alekyan, B G; Karapetyan, N G; Chupin, A V; Zotikov, A E; Varava, A B; Knish, Ju B; Sedgaryan, M A.
  • Alekyan BG; Vishnevsky National Medical Research Center of Surgery, Moscow.
  • Karapetyan NG; Vishnevsky National Medical Research Center of Surgery, Moscow.
  • Chupin AV; Vishnevsky National Medical Research Center of Surgery, Moscow.
  • Zotikov AE; Vishnevsky National Medical Research Center of Surgery, Moscow.
  • Varava AB; Vishnevsky National Medical Research Center of Surgery, Moscow.
  • Knish JB; Vishnevsky National Medical Research Center of Surgery, Moscow.
  • Sedgaryan MA; Vishnevsky National Medical Research Center of Surgery, Moscow.
Kardiologiia ; 62(9): 37-43, 2022 Sep 30.
Article in Russian, English | MEDLINE | ID: covidwho-2307193
ABSTRACT
Aim      To compare long-term outcomes of x-ray endovascular (percutaneous coronary intervention, PCI, and lower limb angioplasty with stent placement, LLA; group 1) and combination treatments (PCI and open LLA surgery; group 2) in patients with chronic lower limb ischemia (CLLI) associated with ischemic heart disease (IHD).Material and methods  This retrospective study has been conducted in the Vishnevsky National Medical Research Center of Surgery since 2019. The study includes 92 patients with stage 2B CLLI associated with IHD who were managed from January 1, 2017 through December 31, 2020. Long-term outcomes were evaluated in 76 (82.6 %) patients. The endpoint was severe cardiovascular complications (CVC), including death, myocardial infarction, and acute cerebrovascular disease (ACVD).Results In group 1 during the long-term period, 1 (2.7%) fatal outcome due to pneumonia was observed. In group 2, 4 (10 %) patients died 1 (2.5 %) patient due to ACVD, 1 (2.5 %) patient due to progression of oncological process, and 2 2 (5 %) patients due to COVID-19. Also, 2 (5.5 %) and 1 (2.5 %) cases of acute coronary syndrome (ACS) were observed in groups 1 and 2, respectively (p=0.61).Conclusion      In the x-ray endovascular (group1) and the combination (group 2) intervention groups, lethal outcomes due to myocardial infarction were absent. This fact confirms the importance of PCI in patients with CLLI for prevention of possible ACS in the long-term. Both therapeutic tactics in managing CLLI patients with IHD demonstrated high safety and clinical efficacy during the hospital and long-term periods and can be extensively used in routine clinical practice.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Myocardial Ischemia / Acute Coronary Syndrome / Percutaneous Coronary Intervention / COVID-19 / Myocardial Infarction Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Long Covid Limits: Humans Language: English / Russian Journal: Kardiologiia Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Myocardial Ischemia / Acute Coronary Syndrome / Percutaneous Coronary Intervention / COVID-19 / Myocardial Infarction Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Long Covid Limits: Humans Language: English / Russian Journal: Kardiologiia Year: 2022 Document Type: Article